19 June 2013
Keywords: pfizer, initiates, ph, iii, sutent, trial, nsclc
Article | 17 September 2007
US drug giant Pfizer says it has initiated a global Phase III evaluation of Sutent (sunitinib malate) in combination with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 September 2007
© 2013 thepharmaletter.com